Satio Receives Funding From ARPA-H to Develop SatioRx™ a Novel At-home, Remotely Controllable Transdermal Drug Delivery Device

BOSTON, Sept. 26, 2023 /PRNewswire/ — Satio is pleased to announce a $3.5 million Small Business Innovation Research (SBIR) contract awarded by the Advanced Research Projects Agency for Health (ARPA-H), National Institutes of Health, Department of Health and Human Services. This SatioRx™ device is designed to be compact and inexpensive, with disposable microneedle components that allow health care providers to remotely […]

Satio partners with BARDA DRIVe to develop a novel patch-based ebolavirus diagnostic

Satio is pleased to announce a contract awarded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services to develop a novel, single-use, rapid ebolavirus diagnostic.  This groundbreaking diagnostic will combine Satio’s patch-based blood collection device with Institut […]

Satio and INTACT Form Strategic Partnership to Jointly Improve Delivery of Mass Vaccination

Satio and INTACT Solutions have entered into an agreement to establish a collaborative framework in order to partner on research, development, manufacture, and deployment of next generation health technologies with the goal of offering alternative solutions to traditional needles with SatioRx™ intradermal patches for the Member States of the African Union and beyond.